DP
DSAM Partners’s Allogene Therapeutics ALLO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $1.39M | Sell |
54,000
-90,000
| -63% | -$2.31M | 0.79% | 17 |
|
2021
Q2 | $3.76M | Sell |
144,000
-41,142
| -22% | -$1.07M | 0.63% | 31 |
|
2021
Q1 | $6.54M | Sell |
185,142
-23,656
| -11% | -$835K | 1.21% | 21 |
|
2020
Q4 | $5.27M | Buy |
208,798
+25,798
| +14% | +$651K | 0.62% | 44 |
|
2020
Q3 | $6.9M | Sell |
183,000
-52,098
| -22% | -$1.96M | 1.19% | 23 |
|
2020
Q2 | $10.1M | Buy |
235,098
+203,490
| +644% | +$8.71M | 2.63% | 13 |
|
2020
Q1 | $614K | Sell |
31,608
-3,203
| -9% | -$62.2K | 0.15% | 25 |
|
2019
Q4 | $904K | Sell |
34,811
-72,630
| -68% | -$1.89M | 0.21% | 37 |
|
2019
Q3 | $2.93M | Sell |
107,441
-158,828
| -60% | -$4.33M | 0.55% | 41 |
|
2019
Q2 | $7.15M | Sell |
266,269
-224,169
| -46% | -$6.02M | 0.89% | 39 |
|
2019
Q1 | $14.2M | Sell |
490,438
-159,169
| -25% | -$4.6M | 2.05% | 21 |
|
2018
Q4 | $17.5M | Buy |
+649,607
| New | +$17.5M | 3.64% | 9 |
|